PlainRecalls
FDA Drug Low Class III Terminated

Fentanyl Transdermal System, 50 mcg/h, 1 system per pouch (NDC 0591-3212-54), packaged in 5-count systems per box (NDC 0591-3212-72), Rx only, Manufactured by Watson Laboratories, Inc, Corona, CA, 92880 USA; Distributed by: Watson Pharma, Inc.

Reported: June 19, 2013 Initiated: June 3, 2013 #D-599-2013

Product Description

Fentanyl Transdermal System, 50 mcg/h, 1 system per pouch (NDC 0591-3212-54), packaged in 5-count systems per box (NDC 0591-3212-72), Rx only, Manufactured by Watson Laboratories, Inc, Corona, CA, 92880 USA; Distributed by: Watson Pharma, Inc.

Reason for Recall

Failed Impurities/Degradation Specifications

Details

Recalling Firm
Actavis
Units Affected
98,952 boxes
Distribution
Nationwide
Location
Salt Lake City, UT

Frequently Asked Questions

What product was recalled?
Fentanyl Transdermal System, 50 mcg/h, 1 system per pouch (NDC 0591-3212-54), packaged in 5-count systems per box (NDC 0591-3212-72), Rx only, Manufactured by Watson Laboratories, Inc, Corona, CA, 92880 USA; Distributed by: Watson Pharma, Inc.. Recalled by Actavis. Units affected: 98,952 boxes.
Why was this product recalled?
Failed Impurities/Degradation Specifications
Which agency issued this recall?
This recall was issued by the FDA Drug on June 19, 2013. Severity: Low. Recall number: D-599-2013.